Tyler Stone Wealth Management acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 8,000 shares of the company's stock, valued at approximately $386,000.
Other institutional investors have also recently modified their holdings of the company. Cherry Tree Wealth Management LLC bought a new position in shares of Tempus AI during the 1st quarter valued at about $31,000. University of Texas Texas AM Investment Management Co. bought a new position in shares of Tempus AI during the 1st quarter valued at about $33,000. Bartlett & CO. Wealth Management LLC increased its position in shares of Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Nemes Rush Group LLC bought a new position in shares of Tempus AI during the 1st quarter valued at about $39,000. Finally, Continuum Advisory LLC bought a new position in shares of Tempus AI during the 1st quarter valued at about $39,000. 24.22% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. Guggenheim increased their target price on Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a report on Monday, June 30th. Bank of America increased their target price on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. BTIG Research initiated coverage on Tempus AI in a report on Friday, August 8th. They set a "buy" rating and a $60.00 target price for the company. Finally, Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a report on Friday, August 8th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Tempus AI has a consensus rating of "Moderate Buy" and a consensus target price of $65.36.
View Our Latest Report on Tempus AI
Insider Transactions at Tempus AI
In related news, CEO Eric P. Lefkofsky sold 250,000 shares of the firm's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $70.07, for a total transaction of $17,517,500.00. Following the completion of the transaction, the chief executive officer owned 9,357,283 shares of the company's stock, valued at $655,664,819.81. This trade represents a 2.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO James William Rogers sold 23,121 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.27, for a total value of $1,462,865.67. Following the transaction, the chief financial officer directly owned 146,001 shares of the company's stock, valued at approximately $9,237,483.27. This trade represents a 13.67% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 802,772 shares of company stock worth $54,080,775. 27.60% of the stock is owned by insiders.
Tempus AI Trading Up 3.1%
NASDAQ TEM opened at $73.78 on Friday. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $91.45. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.56 and a current ratio of 1.54. The stock has a 50 day simple moving average of $63.13 and a two-hundred day simple moving average of $58.63. The stock has a market cap of $12.77 billion, a P/E ratio of -62.00 and a beta of 4.98.
Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%. The business had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. During the same quarter last year, the business posted ($6.86) EPS. The business's revenue was up 89.5% on a year-over-year basis. On average, analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
About Tempus AI
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.